agtc-8k_20160208.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 8, 2016

 

APPLIED GENETIC TECHNOLOGIES CORPORATION

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

 

001-36370

 

59-3553710

(State or Other Jurisdiction

of Incorporation)

 

(Commission File Number)

 

(IRS Employer

Identification No.)

 

 

 

 

 

14193 NW 119th Terrace

Suite 10

Alachua, Florida

 

 

 

32615

(Address of Principal Executive Offices)

 

 

 

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (386) 462-2204  

11801 Research Drive,

Suite D

Alachua, Florida 32615

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

 


 

Item 2.02.   Results of Operations and Financial Condition

On February 8, 2016, Applied Genetic Technologies Corporation issued a press release entitled “AGTC Announces Financial Results for the Quarter Ended December 31, 2015.”  The earnings release is furnished as Exhibit 99.1.

Item 9.01.   Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

Description

99.1

Press release dated February 8, 2016, entitled “AGTC Announces Financial Results for the Quarter Ended December 31, 2015”

 

 

 

2


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

APPLIED GENETIC TECHNOLOGIES CORPORATION

 

 

 

 

 

 

 

 

Date:   February 8, 2016

 

By:

/s/ Lawrence E. Bullock

 

 

 

 

Lawrence E. Bullock

 

 

 

 

Chief Financial Officer

 


 

3


 

Exhibit Index

Exhibit No.

Description

99.1

Press release dated February 8, 2016, entitled “AGTC Announces Financial Results for the Quarter Ended December 31, 2015”

 

 

 

4